Showing 1 - 13 results of 13 for search '"Drug Approval United States"', query time: 0.19s Refine Results
  1. 1
    PDUFA V : medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011.
    Published 2012
    Subjects: “...Drug approval United States....”
    Get full text
    Government Document eBook
  2. 2
    Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.
    Published 2015
    Subjects: “...Drug approval United States....”
    Get full text
    Get full text
    Government Document eBook
  3. 3
    FDA user fees 2012 : how innovation helps patients and jobs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, April 18, 2012.
    Published 2013
    Subjects: “...Drug approval United States....”
    Get full text
    Get full text
    Government Document eBook
  4. 4
    Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
    Published 2008
    Subjects: “...Drug approval United States....”
    Get full text
    Government Document eBook
  5. 5
    FDA user fees 2012 : issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012.
    Published 2013
    Subjects: “...Drug approval United States....”
    Get full text
    Get full text
    Government Document eBook
  6. 6
    Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
    Published 2013
    Subjects: “...Drug approval United States....”
    Get full text
    Get full text
    Government Document eBook
  7. 7
    Reviewing FDA's implementation of FDASIA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, November 15, 2013.
    Published 2014
    Subjects: “...Drug approval United States....”
    Get full text
    Get full text
    Government Document eBook
  8. 8
    PDUFA V : medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011.
    Published 2012
    Subjects: “...Drug approval United States. http://id.loc.gov/authorities/subjects/sh2009123884...”
    Electronic resource (PDF)
    Government Document eBook
  9. 9
    The impact of medical device and drug regulation on innovation, jobs, and patients : a local perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 26, 2011.
    Published 2012
    Subjects: “...Drug approval United States. http://id.loc.gov/authorities/subjects/sh2009123884...”
    Electronic resource (PDF)
    Government Document eBook
  10. 10
    Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
    Published 2008
    Subjects: “...Drug approval United States. http://id.loc.gov/authorities/subjects/sh2009123884...”
    Electronic resource (PDF)
    Government Document eBook
  11. 11
    The impact of medical device and drug regulation on innovation, jobs, and patients : a local perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 26, 2011.
    Published 2012
    Subjects: “...Drug approval United States....”
    Get full text
    Government Document eBook
  12. 12
    Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 14, 2018.
    Published 2018
    Subjects: “...Drug approval United States Costs....”
    Get full text
    Government Document eBook
  13. 13
    Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
    Published 2018
    Subjects: “...Drug approval United States. http://id.loc.gov/authorities/subjects/sh2009123884...”
    Get full text
    Government Document eBook
Search Tools: RSS Feed – Email Search